199 related articles for article (PubMed ID: 37076996)
1. Time trends and survival of marginal zone lymphoma over 25 years in Girona, Spain (1994-2018).
Auñón C; Sanvisens A; Turon E; Vidal-Vila A; Puigdemont M; Osca-Gelis G; Eraso A; Marcos-Gragera R
Cancer Med; 2023 Jun; 12(11):12343-12353. PubMed ID: 37076996
[TBL] [Abstract][Full Text] [Related]
2. Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sites.
Kuper-Hommel MJ; van de Schans SA; Vreugdenhil G; van Krieken JH; Coebergh JW
Leuk Lymphoma; 2013 Sep; 54(9):1891-7. PubMed ID: 23302044
[TBL] [Abstract][Full Text] [Related]
3. Primary nodal marginal zone lymphomas of splenic and MALT type.
Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
[TBL] [Abstract][Full Text] [Related]
4. Marginal zone lymphoma.
Shaye OS; Levine AM
J Natl Compr Canc Netw; 2006 Mar; 4(3):311-8. PubMed ID: 16507274
[TBL] [Abstract][Full Text] [Related]
5. Marginal zone lymphomas.
Zucca E; Rossi D; Bertoni F
Hematol Oncol; 2023 Jun; 41 Suppl 1():88-91. PubMed ID: 37294969
[TBL] [Abstract][Full Text] [Related]
6. Transformation and survival in marginal zone lymphoma: a Finnish nationwide population-based study.
Kalashnikov I; Tanskanen T; Viisanen L; Malila N; Jyrkkiö S; Leppä S
Blood Cancer J; 2023 Apr; 13(1):62. PubMed ID: 37185610
[TBL] [Abstract][Full Text] [Related]
7. Transformation to diffuse large B-cell lymphoma and its impact on survival in patients with marginal zone lymphoma: A population-based study.
Du Y; Wang Y; Li Q; Chang X; Shen K; Zhang H; Xiao M; Xing S
Int J Cancer; 2024 Mar; 154(6):969-978. PubMed ID: 37874120
[TBL] [Abstract][Full Text] [Related]
8. Genomic analysis of non-splenic marginal zone lymphomas (MZL) indicates similarities between nodal and extranodal MZL and supports their derivation from memory B-cells.
Novak U; Basso K; Pasqualucci L; Dalla-Favera R; Bhagat G
Br J Haematol; 2011 Nov; 155(3):362-5. PubMed ID: 21883140
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
[TBL] [Abstract][Full Text] [Related]
10. Marginal zone lymphomas: factors that affect the final outcome.
Mazloom A; Medeiros LJ; McLaughlin PW; Reed V; Cabanillas FF; Fayad LE; Pro B; Gonzalez G; Iyengar P; Urbauer DL; Dabaja BS
Cancer; 2010 Sep; 116(18):4291-8. PubMed ID: 20549822
[TBL] [Abstract][Full Text] [Related]
11. Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site.
Khalil MO; Morton LM; Devesa SS; Check DP; Curtis RE; Weisenburger DD; Dores GM
Br J Haematol; 2014 Apr; 165(1):67-77. PubMed ID: 24417667
[TBL] [Abstract][Full Text] [Related]
12. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.
Nathwani BN; Anderson JR; Armitage JO; Cavalli F; Diebold J; Drachenberg MR; Harris NL; MacLennan KA; Müller-Hermelink HK; Ullrich FA; Weisenburger DD
J Clin Oncol; 1999 Aug; 17(8):2486-92. PubMed ID: 10561313
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in understanding the biology of marginal zone lymphoma.
Bertoni F; Rossi D; Zucca E
F1000Res; 2018; 7():406. PubMed ID: 29657712
[TBL] [Abstract][Full Text] [Related]
14. Histologic transformation in marginal zone lymphomas†.
Conconi A; Franceschetti S; Aprile von Hohenstaufen K; Margiotta-Casaluci G; Stathis A; Moccia AA; Bertoni F; Ramponi A; Mazzucchelli L; Cavalli F; Gaidano G; Zucca E
Ann Oncol; 2015 Nov; 26(11):2329-35. PubMed ID: 26400898
[TBL] [Abstract][Full Text] [Related]
15. Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study.
Oh SY; Kim WS; Kim JS; Kim SJ; Lee S; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Kang HJ; Choi CW; Park J; Kim HJ; Kwon JH; Lee HS; Lee GW; Eom HS; Kwak JY; Lee WS; Suh C; Kim HJ
Int J Hematol; 2010 Oct; 92(3):510-7. PubMed ID: 20838958
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of the novel marginal zone B-cell marker IRTA1 in malignant lymphoma.
Ikeda JI; Kohara M; Tsuruta Y; Nojima S; Tahara S; Ohshima K; Kurashige M; Wada N; Morii E
Hum Pathol; 2017 Jan; 59():70-79. PubMed ID: 27666766
[TBL] [Abstract][Full Text] [Related]
17. Marginal Zone Lymphomas.
Bertoni F; Rossi D; Raderer M; Zucca E
Cancer J; 2020; 26(4):336-347. PubMed ID: 32732678
[TBL] [Abstract][Full Text] [Related]
18. Waldeyer's ring marginal zone B cell lymphoma: are the clinical and prognostic features nodal or extranodal? A study by the Consortium for Improving Survival of Lymphoma (CISL).
Oh SY; Kim WS; Kim JS; Kim SJ; Lee S; Lee DH; Lee SI; Kang HJ; Choi CW; Park J; Song MK; Kim HJ; Kwon JH; Kwak JY; Bae SH; Park BB; Do YR; Lee HS; Jeong SH; Suh C; Kim HJ
Int J Hematol; 2012 Nov; 96(5):631-7. PubMed ID: 23065471
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma: an analysis of clinical presentation and outcome in 144 patients.
Heilgeist A; McClanahan F; Ho AD; Witzens-Harig M
Cancer; 2013 Jan; 119(1):99-106. PubMed ID: 22736411
[TBL] [Abstract][Full Text] [Related]
20. Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pylori interventions: results from a population-based study on extranodal marginal zone lymphomas.
Luminari S; Cesaretti M; Marcheselli L; Rashid I; Madrigali S; Maiorana A; Federico M
Ann Oncol; 2010 Apr; 21(4):855-859. PubMed ID: 19850642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
